Thyrocare Technologies quarterly results and financials

Thyrocare Technologies (THYROCARE)₹485.30−2.74%(9 Nov 2026 close)Healthcare Service Provider

Key facts

In the Sep 2026 quarter (consolidated), Thyrocare Technologies reported sales of ₹272 Cr, up 24.8% from Sep 2025, and net profit of ₹15.06 Cr, down 68.7% year on year. For the year to Mar 2026, sales were ₹832 Cr and net profit ₹163 Cr.

Sales (Sep 2026): ₹272 Cr
Net profit (Sep 2026): ₹15.06 Cr
Sales (FY Mar 2026): ₹832 Cr
Net profit (FY Mar 2026): ₹163 Cr
EPS (Sep 2026): ₹0.99
Borrowings (Mar 2026): ₹51.05 Cr

Company filings, consolidated accounts; latest reported quarter Sep 2026

Thyrocare Technologies quarterly results

₹ crore unless stated; each column is a quarter.

Thyrocare Technologies Quarterly results
	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Sales	135	154	157	178	167	188	194	218	197	225	241	272
Expenses	103	121	115	129	124	130	135	145	138	149	163	182
Operating Profit	31.87	33.86	41.82	47.82	41.85	56.80	57.74	70.73	57.73	74.68	76.68	88.61
OPM %	23.1%	22.1%	27.1%	27.1%	25.1%	30.1%	30.1%	33.1%	30.1%	34.1%	32.1%	33.0%
Other Income	2.99	2.99	3.98	2.99	3.99	4.98	4.98	2.99	−0.99	4.98	4.98	−40.88
Interest	1.01	1.01	1.01	1.01	1.01	1.01	1.01	1.01	0.00	2.01	1.01	2.01
Depreciation	12.98	12.98	10.98	12.97	16.96	13.98	10.98	11.98	21.96	13.98	11.98	13.96
Profit before tax	20.06	23.08	34.09	37.15	28.10	47.13	50.16	63.21	35.13	64.16	68.24	34.13
Tax %	26.0%	25.0%	28.9%	27.9%	31.9%	54.0%	23.9%	23.9%	20.9%	24.0%	24.9%	54.9%
Exceptional items	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	−4.42	0.00	0.00	−26.51
Net Profit	15.06	17.07	24.11	26.09	19.06	22.09	38.14	48.19	28.11	49.14	51.20	15.06
EPS (Rs)	0.96	1.11	1.51	1.67	1.19	1.35	2.44	3.01	1.81	2.95	3.27	0.99

Thyrocare Technologies profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Thyrocare Technologies Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	242	305	357	404	436	496	591	529	574	689	832	934
Expenses	147	189	212	249	260	322	353	402	431	497	565	631
Operating Profit	93.65	115	144	153	173	170	235	122	139	189	262	298
OPM %	39.1%	38.1%	41.1%	38.0%	40.0%	35.1%	40.1%	23.1%	24.1%	28.1%	32.1%	31.9%
Other Income	6.98	−14.96	20.92	10.96	0.99	11.96	28.89	8.97	8.96	14.95	11.96	−31.91
Interest	1.01	0.00	0.00	1.01	2.01	1.01	3.01	5.01	6.01	4.01	4.01	5.03
Depreciation	17.97	17.97	19.95	25.93	31.95	29.96	33.92	38.92	46.93	54.91	58.91	61.88
Profit before tax	82.29	82.28	145	139	140	153	229	89.31	96.33	145	214	202
Tax %	37.0%	47.9%	35.9%	37.9%	37.0%	25.9%	23.0%	27.0%	28.0%	38.0%	24.0%	—
Exceptional items	0.99	−12.98	2.99	2.99	−0.99	5.99	18.96	0.00	−0.99	4.99	1.99	−30.93
Net Profit	52.22	43.18	93.34	85.26	88.25	113	177	64.25	69.30	91.35	163	144
EPS (Rs)	3.20	2.65	5.78	5.37	5.57	7.12	11.08	4.05	4.44	5.75	10.23	9.02
Dividend payout %	104.0%	125.0%	57.9%	123.9%	29.9%	117.0%	44.9%	147.9%	134.9%	122.0%	136.9%	—

Thyrocare Technologies balance sheet

₹ crore, at each year end.

Thyrocare Technologies Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	51.19	54.09	54.12	54.21	53.24	53.21	53.19	53.22	53.20	53.18	53.18	160
Reserves	226	312	354	390	382	314	374	474	481	474	494	426
Borrowings	0.00	0.00	0.00	0.00	1.99	11.99	7.99	21.01	23.00	42.00	25.03	51.05
Other Liabilities	52.82	43.79	29.85	35.88	36.86	89.65	106	59.94	73.64	74.64	121	111
Total Liabilities	329	410	438	479	475	469	541	607	632	643	693	747
Fixed Assets	196	259	259	299	294	269	252	285	293	305	297	317
CWIP	6.01	1.01	17.03	0.00	1.01	5.01	8.01	3.01	2.01	3.01	14.02	3.01
Investments	85.86	92.91	104	120	94.94	89.83	126	146	144	162	162	177
Other Assets	42.10	56.12	58.16	60.11	84.16	105	154	173	192	173	220	250
Inventories	6.99	10.97	13.98	16.97	17.96	20.95	22.97	24.96	27.93	47.88	46.90	47.90
Trade receivables	5.01	8.01	6.01	10.01	12.01	15.99	45.04	92.97	85.02	43.02	73.07	74.03
Cash & equivalents	4.99	9.98	11.97	11.98	9.97	10.97	15.97	13.96	27.92	39.91	53.89	67.83
Total Assets	329	410	438	479	475	469	541	607	632	643	693	747

Thyrocare Technologies cash flow

₹ crore, for each year.

Thyrocare Technologies Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	34.11	68.22	90.35	107	100	169	116	113	130	169	192	214
Cash from investing activity	−18.08	−18.06	−42.15	−43.15	−12.05	1.01	−49.20	−24.11	−39.16	−91.35	−53.20	−23.09
Cash from financing activity	−22.98	−44.97	−49.02	−63.98	−93.90	−165	−61.99	−88.92	−85.95	−84.92	−130	−170
Net cash flow	−6.01	5.01	0.00	0.00	−5.01	4.01	4.01	0.00	4.01	−8.01	8.02	21.04
Capex	10.01	14.46	36.44	43.73	40.35	9.92	26.77	37.92	43.78	61.74	44.96	20.94
Free cash flow	24.94	52.83	52.89	62.86	60.87	158	92.75	98.71	87.76	107	146	197
CFO / OP %	79.0%	106.1%	113.1%	108.1%	104.0%	122.0%	92.0%	72.0%	128.0%	141.0%	123.1%	104.0%

Thyrocare Technologies ratios

Working-capital days and returns, by year.

Thyrocare Technologies Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	11	12	9	11	12	15	34	59	60	29	40	34
Inventory days	48	56	65	66	60	64	52	53	62	104	89	81
Days payable	5	10	6	25	25	68	56	36	54	88	146	109
Cash conversion cycle	53	57	67	50	46	10	29	75	67	44	−18	4
Working capital days	27	1	18	9	27	−9	18	40	30	6	12	18
ROCE %	—	24.1%	28.1%	33.1%	30.1%	35.1%	36.1%	42.1%	17.1%	18.1%	25.1%	35.1%

Thyrocare Technologies: frequently asked questions

What are the latest quarterly results of Thyrocare Technologies?

For the Sep 2026 quarter, Thyrocare Technologies reported sales of ₹272 Cr, up 24.8% year on year and net profit of ₹15.06 Cr, down 68.7% year on year. The operating margin was 33.0%.

What is the annual revenue of Thyrocare Technologies?

Thyrocare Technologies' sales for the year to Mar 2026 were ₹832 Cr; over the last twelve months they were ₹934 Cr.

What is the net profit of Thyrocare Technologies?

Net profit for the year to Mar 2026 was ₹163 Cr, and ₹144 Cr over the last twelve months. Earnings per share over the same trailing period were ₹9.02.

How much debt does Thyrocare Technologies have?

Thyrocare Technologies reported borrowings of ₹51.05 Cr at Mar 2026, against cash and equivalents of ₹67.83 Cr.

What is the free cash flow of Thyrocare Technologies?

Cash from operations was ₹214 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹197 Cr.

Loading…